BIOLASE INC (BIOL)

US0909117022 - Common Stock

0.148  0 (0%)

After market: 0.148 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025
Revenue
YoY % growth
39.19M
72.04%		48.46M
23.65%		49.164M
1.45%		52.532M
6.85%
EBITDA
YoY % growth
-15.72M
12.86%		-24.84M
-58.02%		-15.139M
39.05%		-2.499M
83.49%
EBIT
YoY % growth
-16.12M
13.05%		-25.34M
-57.20%		-17.937M
29.21%		-7.253M
59.56%
Operating Margin
-41.13%-52.29%-36.48%-13.81%
EPS
YoY % growth
-3.25
62.86%		-410.00
-12,515.38%		-31.89
92.22%		-0.33
98.98%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.17
99.04%
Revenue
Q2Q % growth		10.196M
-2.62%
EBITDA
Q2Q % growth		-2.295M
EBIT
Q2Q % growth		-3.756M
29.00%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -1.76
98.63%		-2.610.8532.47%
Q3 2023
Q2Q % growth		 -3.89
96.46%		-1.89-2.00-106.15%
Q2 2023
Q2Q % growth		 -8.24
90.95%		-5.44-2.80-51.48%
Q1 2023
Q2Q % growth		 -18.00
77.78%		-20.062.0610.27%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 13.49M
-3.99%		13.82M-330K-2.39%
Q3 2023
Q2Q % growth		 10.92M
-9.08%		14.237M-3.317M-23.30%
Q2 2023
Q2Q % growth		 14.29M
16.75%		15.664M-1.374M-8.77%
Q1 2023
Q2Q % growth		 10.47M
2.95%		10.382M88K0.85%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS80.9% 90.56% 82.66% 93.44%
Revenue-7.41% -9.83% -2.95% -2.49%